Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Permian Resources Corporation Class A Common Stock (PR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Permian Resources Corporation Class A Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Permian Resources Corporation Class A Common Stock trades at $23.03 (market cap $19.13B). The key difference: Permian Resources Corporation Class A Common Stock is the larger of the two by market cap, and Permian Resources Corporation Class A Common Stock pays a 2.76% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Permian Resources Corporation Class A Common Stock for 0 Days on average.
| HALO | PR | |
|---|---|---|
Market Cap | $12.58B | $19.13B |
Volume | 2,179,278 | 7,451,304 |
Sector | Health | Energy |
52-Week High | $115.22 | $24.49 |
52-Week Low | $61.63 | $12.09 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $14.49B | $22.13B |
Dividend Yield | — | 2.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Permian Resources Corporation Class A Common Stock
Permian Resources explores for and produces oil and natural gas in the Permian Basin. Its operations are concentrated in the Delaware Basin of West Texas and New Mexico.
Read more on PR →
